NCT07210034View on ClinicalTrials.gov

What is the Prognostic Value of HALP Score, Monocytopenia, Hypofibrinogenemia, and AST/ALT Ratio in Patients With Myelodysplastic Syndromes

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

January 1, 2028

Study Completion Date

March 1, 2028

Conditions

Myelo Dysplastic Syndrome

All Listed Sponsors

lead

Assiut University

OTHER